Intraneuronal Aβ accumulation precedes plaque formation in β-amyloid precursor protein and presenilin-1 double-transgenic mice

被引:275
作者
Wirths, O
Multhaup, G
Czech, C
Blanchard, V
Moussaoui, S
Tremp, G
Pradier, L
Beyreuther, K
Bayer, TA
机构
[1] Univ Bonn, Med Ctr, Dept Psychiat, D-53105 Bonn, Germany
[2] ZMBH, D-69120 Heidelberg, Germany
[3] Aventis Pharma, Neurodegenerat Dis Grp, F-94403 Vitry Sur Seine, France
关键词
intraneuronal abeta; immunohistochemistry; post-mortem; transgenic mouse; Western blot; platelet-derived growth factor beta;
D O I
10.1016/S0304-3940(01)01876-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
beta -Amyloid peptides are key molecules that are involved in the pathology of Alzheimer's disease (AD). The source and place of the neurotoxic action of A beta, however, is still a matter of controversial debates. In the present report, we studied the neuropathological events in a transgenic mouse model expressing human mutant beta -amyloid precursor protein and human mutant presenilin-1 in neurons. Western blot and immunohistochemical analysis revealed that intracellular A beta staining preceded plaque deposition, which started in the hippocampal formation. At later stages, many neuritic A beta positive plaques were found in all cortical, hippocampal and many other brain areas. Interestingly, intraneuronal A beta staining was no longer detected in the brain of aged double-transgenic mice, which correlates with the typical neuropathology in the brain of chronic AD patients. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:116 / 120
页数:5
相关论文
共 19 条
[1]  
Bayer TA, 2001, BRAIN PATHOL, V11, P1
[2]   Plaque formation in brain transplants exposed to human beta-amyloid precursor protein 695 [J].
Bayer, TA ;
Fossgreen, A ;
Czech, C ;
Beyreuther, K ;
Wiestler, OD .
ACTA NEUROPATHOLOGICA, 1996, 92 (02) :130-137
[3]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[4]   Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation [J].
Chui, DH ;
Tanahashi, H ;
Ozawa, K ;
Ikeda, S ;
Checler, F ;
Ueda, O ;
Suzuki, H ;
Araki, W ;
Inoue, H ;
Shirotani, K ;
Takahashi, K ;
Gallyas, F ;
Tabira, T .
NATURE MEDICINE, 1999, 5 (05) :560-564
[5]   Alzheimer's A beta(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells [J].
Cook, DG ;
Forman, MS ;
Sung, JC ;
Leight, S ;
Kolson, DL ;
Iwatsubo, T ;
Lee, VMY ;
Doms, RW .
NATURE MEDICINE, 1997, 3 (09) :1021-1023
[6]   Proteolytical processing of mutated human amyloid precursor protein in transgenic mice [J].
Czech, C ;
Delaere, P ;
Macq, AF ;
Reibaud, M ;
Dreisler, S ;
Touchet, N ;
Schombert, B ;
Mazadier, M ;
Mercken, L ;
Theisen, M ;
Pradier, L ;
Octave, JN ;
Beyreuther, K ;
Tremp, G .
MOLECULAR BRAIN RESEARCH, 1997, 47 (1-2) :108-116
[7]  
Glenner G G, 1984, Appl Pathol, V2, P357
[8]   ALZHEIMERS-DISEASE - INITIAL REPORT OF THE PURIFICATION AND CHARACTERIZATION OF A NOVEL CEREBROVASCULAR AMYLOID PROTEIN [J].
GLENNER, GG ;
WONG, CW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 120 (03) :885-890
[9]   Intraneuronal Aβ42 accumulation in human brain [J].
Gouras, GK ;
Tsai, J ;
Naslund, J ;
Vincent, B ;
Edgar, M ;
Checler, F ;
Greenfield, JP ;
Haroutunian, V ;
Buxbaum, JD ;
Xu, HX ;
Greengard, P ;
Relkin, NR .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (01) :15-20
[10]   AMYLOID BETA-PEPTIDE IS PRODUCED BY CULTURED-CELLS DURING NORMAL METABOLISM [J].
HAASS, C ;
SCHLOSSMACHER, MG ;
HUNG, AY ;
VIGOPELFREY, C ;
MELLON, A ;
OSTASZEWSKI, BL ;
LIEBERBURG, I ;
KOO, EH ;
SCHENK, D ;
TEPLOW, DB ;
SELKOE, DJ .
NATURE, 1992, 359 (6393) :322-325